Oligopeptide functional food and preparation method thereof

Abstract

The invention relates to an oligopeptide functional food and a preparation method thereof. The oligopeptide functional food is prepared from, by weight, 15-21 parts of skipjack oligopeptide, 12-20 parts of whey oligopeptide, 8-17 parts of corn oligopeptide, 6-12 parts of sipunculid oligopeptide, 3-15 parts of a cistanche deserticola extract, 4-12 parts of an astragalus extract, 2-10 parts of a poria cocos extract, 2-8 parts of a cornus extract and 0.01-0.1 part of decavitamin. The oligopeptide functional food is safe, has no toxic and side effects, neither can generate dependency and drug resistance, nor can be accumulated in the body, has a synergistic effect on cells, tissue and metaboilic level while ensuring low purine ingestion, inhibits synthesis of uric acid, promotes excretion of the uric acid, also repairs the damaged liver and kidney tissue, ensures the smooth circulation of the uric acid in the body, and achieves the effect of addressing both symptoms and root causes. The preparation method has the advantages that the main active ingredients can be retained to the utmost extent, the yield is increased, the extraction and preparation time can also be effectively reduced,and the energy consumption is reduced.

Description

technical field [0001] The invention relates to the technical field of functional food, in particular to an oligopeptide functional food suitable for people with hyperuricemia and gout and a preparation method thereof. Background technique [0002] Uric acid is the end product of purine metabolism in most animals. Hyperuricemia (HUA) may occur when the production of uric acid in animals increases and / or the excretion and decomposition decrease, resulting in the accumulation of uric acid. When the uric acid in the serum rises to a supersaturated state, sodium urate crystals will be formed and deposited in the synovium, bursa, cartilage and other tissues to cause gout, leading to joint redness, swelling and pain, and even joint deformity and dysfunction. In addition, patients with hyperuricemia not only have a high incidence of oral cancer, liver cancer and other diseases, but are also closely related to metabolic diseases such as obesity, hypertension, hyperglycemia, and hype...

AI Technical Summary

Problems solved by technology

[0004] Modern medicine mainly uses benzbromarone, which promotes the excretion of uric acid, allopurinol and febuxostat, which inhibit the synthesis of uric acid, non-steroidal anti-inflammatory drugs and colchicine, etc. to treat hyperuricemia and gout. Although the drug has received short-term curative effect, the recurrence rate is high and the dependence is strong. Long-term use has obvious toxic side effects such as liver and kidney damage, bone marrow suppression, etc.

Images